Osteopontin: A Protective Mediator of Cardiac Fibrosis?
- 1 December 2004
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 44 (6) , 809-810
- https://doi.org/10.1161/01.hyp.0000148459.25908.49
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Osteopontin Modulates Myocardial Hypertrophy in Response to Chronic Pressure Overload in MiceHypertension, 2004
- Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin II-Induced Cardiac HypertrophyHypertension, 2004
- Osteopontin modulates angiotensin II- induced fibrosis in the intact murine heartJournal of the American College of Cardiology, 2004
- Hypertrophy of the HeartCirculation, 2004
- Osteopontin Inhibits Interleukin-1β-stimulated Increases in Matrix Metalloproteinase Activity in Adult Rat Cardiac FibroblastsPublished by Elsevier ,2003
- Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalJournal of Clinical Investigation, 2001
- The Integrin α9β1 Binds to a Novel Recognition Sequence (SVVYGLR) in the Thrombin-cleaved Amino-terminal Fragment of OsteopontinJournal of Biological Chemistry, 1999
- Altered wound healing in mice lacking a functional osteopontin gene (spp1).Journal of Clinical Investigation, 1998
- Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction.Journal of Clinical Investigation, 1996
- Glucocorticoids Increase Osteopontin Expression in Cardiac Myocytes and Microvascular Endothelial CellsPublished by Elsevier ,1995